Six new medicines accepted for NHS use in Scotland
Cost regulators for NHS treatments in Scotland have backed six medicines offering new options to some patients with cancer, chronic migraine, high cholesterol and iron deficiency.
Read More
Tag: Diafer
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
